Gallagher Brian M. Jr.

CIK 00017099763 companiesCONSHOHOCKEN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001709976

Recent Transactions

24 trades

Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-13+800→ 800 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-19+2,000→ 2,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-22+20,000→ 20,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-20+50,938→ 50,938 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-06-23$1.59/sh+30,000→ 30,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+20,000→ 20,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-10-06+40,000→ 40,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (right to buy)
2021-10-06+40,000→ 40,000 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+4,822,114→ 4,822,114 total
Award
eFFECTOR Therapeutics, Inc.
Earn-out Right
2021-08-25+605,338→ 605,338 total
Conversion
Translate Bio, Inc.
Common Stock
2018-07-02+1,674,016→ 1,674,016 total
Conversion
Translate Bio, Inc.
Common Stock
2018-07-02+1,300,116→ 2,974,132 total
Conversion
Translate Bio, Inc.
Series B Preferred Stock
2018-07-02−7,222,797→ 0 total
Conversion
Translate Bio, Inc.
Common Stock
2018-07-02+454,550→ 3,428,682 total
Purchase
Translate Bio, Inc.
Common Stock
2018-07-02$13.00/sh+269,230→ 3,697,912 total
Conversion
Translate Bio, Inc.
Series C Preferred Stock
2018-07-02−2,525,253→ 0 total
Conversion
Translate Bio, Inc.
Series A Preferred Stock
2018-07-02−9,300,000→ 0 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2017-07-25+20,000→ 20,000 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05$15.00/sh+273,333→ 1,431,519 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+1,158,186→ 1,158,186 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−6,781,770→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-2 Preferred Stock
2017-07-05−1,471,551→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series F Preferred Stock
2017-07-05−1,979,188→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-3 Preferred Stock
2017-07-05−1,276,389→ 0 total

Companies

Recent Filings

Address

C/O S.R. ONE, LIMITED 161 WASHINTON STREET, SUITE 500

CONSHOHOCKEN, PA, 19428

View on SEC.gov